Home Newsfeeds 9 Meters Biopharma Q2 EPS $(0.04) Down From $(0.03) YoY

9 Meters Biopharma Q2 EPS $(0.04) Down From $(0.03) YoY

9 Meters Biopharma (NASDAQ:NMTR) reported quarterly losses of $(0.04) per share. This is a 33.33 percent decrease over losses of $(0.03) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

9 Meters Biopharma (NASDAQ:NMTR) reported quarterly losses of $(0.04) per share. This is a 33.33 percent decrease over losses of $(0.03) per share from the same period last year.

Top 5 Materials Stocks That Could Blast Off This Month

By Lisa Levin

September 11, 8:10 AM

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

CMP

Maxim Group Initiates Coverage On Mobile Global Esports with Buy Rating, Announces Price Target of $1.5

By Benzinga Newsdesk

December 21, 9:46 AM

Maxim Group analyst Jack Vander Aarde initiates coverage on Mobile Global Esports (NASDAQ:MGAM) with a Buy rating and announces Price Target of $1.5.

MGAM

Alibaba Gains, EV Stocks Lose Shine: Hong Kong Traders Keenly Await Tencent Earnings

By Bhavik Nair

August 16, 10:21 PM

Hong Kong’s Hang Seng index opened in the green on Wednesday, gaining 0.3% in morning trade as investors keenly await Tencent’s earnings, along with the New Zealand central bank rate decision.

BABA